help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chopra, I. J.
Right arrow Articles by Solomon, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chopra, I. J.
Right arrow Articles by Solomon, D. H.

Endocrinology, Vol 114, 1295-1301, Copyright © 1984 by Endocrine Society


ARTICLES

A radioimmunoassay of 3,5-dimethyl-3'-isopropyl-L-thyronine

IJ Chopra, TS Huang, RE Hurd and DH Solomon

A simple, sensitive, and specific RIA has been developed to measure 3,5- dimethyl-3'-isopropyl-L-thyronine (DIMIT) in unextracted serum. The RIA employs a DIMIT-binding antibody obtained from a rabbit immunized with DIMIT-human serum albumin conjugate and [125I]T3 as the radioligand. 8- Anilino-1-naphthalene sulfonic acid and barbital buffer (0.075 M; pH 8.6) were used to minimize serum binding of DIMIT and [125I]T3. The detection threshold of the RIA was 0.03 microgram/dl. Recovery of nonradioactive DIMIT added to serum averaged 104%. 3,5,3'- Triiodothyroacetic acid cross-reacted maximally (78%) in the RIA, followed by T3 (56%), 3,5-diethyl-3'-isopropyl thyronine (43%), 3,3'- diiodothyronine (T2; 12%), tetraiodothyroacetic acid (6.7%), 3'- monoiodothyronine (T1; 0.54%), 3.5-T2 (0.34%), 3-T1 (0.26%), and T4 (0.25%); rT3, 3',5'-T2, thyronine, iodotyrosines, and KI cross-reacted 0.1% or less. The coefficient of variation averaged 7.4% within an assay and 9.0% between assays. After ip administration of DIMIT to the rat, the mean serum DIMIT concentration rose in a dose-related fashion from less than 0.12 microgram/dl in the controls to 44 micrograms/dl in those receiving 200 micrograms/100 g BW daily for 3 days; serum T4 and TSH levels declined significantly in animals receiving 3.2 micrograms DIMIT/(100 g BW X day) or more. After a single ip injection of DIMIT to the rat, serum DIMIT levels increased from a control value of 0.04 to 9.8 micrograms/dl at 2 h and then decreased progressively, with a half- life approximating 7.2 h. Serum TSH was suppressed for up to 24 h, while serum T4 and T3 were suppressed for up to 48 h after the injection. Concentrations of DIMIT 15 h after a dose of 10 micrograms, ip, to approximately 150-g rats were (nanograms per g; mean +/- SE) 19 +/- 2.3 in serum, 30 +/- 3.5 in liver, 23 +/- 2.4 in kidney, 19 +/- 4.7 in heart, 16 +/- 3.4 in skeletal muscle, and 20 +/- 3.0 in brain. DIMIT administration to pregnant rats [3 micrograms/(100 g BW X day) for 3 days, im] resulted in mean +/- SE DIMIT concentrations (micrograms per dl) of 0.51 +/- 0.14 in maternal serum, 0.57 +/- 0.04 in fetal serum, and 0.46 +/- 0.07 in amniotic fluid. A DIMIT dose of 10 micrograms/(100 g BW X day) for 3 days in maternal rats resulted in mean DIMIT concentrations (micrograms per dl) of 1.8 +/- 0.06 in maternal serum, 1.4 +/- 0.10 in fetal serum, and 1.3 +/- 0.17 in amniotic fluid.(ABSTRACT TRUNCATED AT 400 WORDS)





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society